News

Genoskin granted a new patent on ex vivo subcutaneous injection model The French National Institute for Intellectual Property (INPI) granted Genoskin's latest patent on its unique ex vivo subcutaneous injection model, HypoSkin®. A boom in the subcutaneous biologics market Today, subcutaneous injection is one of the most common methods to deliver a drug into the human body. Its use has increased significantlyRead more

 Genoskin gives a demonstration of NativeSkin® at the 7th Galenus Workshop The 7th Galenus Workshop will take place at Goethe University Frankfurt from September 30th to October 2nd. Genoskin will present its latest developments and conduct a lab course on how to use our cutting-edge human skin assays. The 2019 Workshop will focus on human in vitro models and act asRead more

Meet with Genoskin at the TechMeetings on Interaction between skin/hair and cosmetics The Synchrotron SOLEIL facilities near Paris, France will welcome the 8th edition of the TechMeetings on October 3rd. Genoskin's Business Development Manager, Michael Pastore will participate in the event. The TechMeetings are organized by the University of Paris-Saclay and the Cosmetic Valley. The event will help create new partnershipsRead more

Genemarkers, LLC and Genoskin, Inc. announce partnership to advance clinical studies of topical solutions September 18, 2019 - Kalamazoo, MI & Salem, MA Genemarkers and Genoskin are pleased to announce they have formed a partnership to provide exceptional value and service to researchers in the fields of cosmetic and pharmaceutical topical solutions. The Companies are currently performing collaborative work toRead more

Genoskin awarded grant from Occitania The Occitania Region announced today that it awarded its coveted international development grant to Genoskin. The “Pass Export” grant is awarded to companies that demonstrate significant growth potential abroad. Pass-Export enables companies to pursue their development in new territories. “Genoskin is honored and grateful to be awarded this grant. As we continue to grow, we

Read more

 [ESDR2019] Genoskin partners with Sanofi to present Hypo-InflammaSkin® Genoskin’s team of skin experts will be presenting its latest work at the 49th ESDR Annual Meeting from September 18 to September 21 in Bordeaux, France. To discover our latest research and innovations, meet our Project Manager and Team leader Claire Jardet, Ph.D.  on Thursday 19th at 7 pm and Friday 20th atRead more